Botulinum Neurotoxins Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Botulinum toxin A, Botulinum toxin B); Application (Medical, Aesthetic); Gender (Female, Male); End- Use (Hospitals, Dermatology Clinics, Spas and cosmetic centers) and Geography

Report Code: TIPRE00018824 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Botulinum neurotoxin is a type of toxic protein produced by clostridium botulinum. This toxin causes a disease called as botulism. Botulinum neurotoxin also has an application in cosmetic and medicine industries. There are seven main subtypes of botulinum toxin A-G among then type A and type B are known to produce diseases in humans and also have applications in cosmetic and medicine industry. The rest type of botulinum are inactive. The side effect of botulinum includes, allergy, back and neck pain, difficulty in swallowing, shortness of breath.

MARKET DYNAMICS

The key market drivers for Botulinum Neurotoxins Market Includes, rising applications of botulinum toxin into cosmetic and therapeutic procedures along with increasing ageing population across the globe. Moreover, rising number of product launch and approvals are also expected to boost market growth during forecast period. Additionally, increase in demand for minimally invasive surgical procedure and non-invasive surgical procedure are also expected to fuel market growth. However, potential side effects from botulinum toxin is expected to restrain market growth during forecast period.

MARKET SCOPE

The "Botulinum Neurotoxins Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Botulinum Neurotoxins market with detailed market segmentation by product, application, gender and end use. The Botulinum Neurotoxins Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Botulinum Neurotoxins Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Botulinum Neurotoxins Market is segmented on the basis of product, application, gender and end use. On the basis of product the market is segmented as, botulinum toxin A, botulinum toxin B. On the basis of application the market is segmented as, medical and aesthetic. On the basis of gender the market is segmented as, female and male. On the basis of end use the market is segmented as, hospitals, dermatology clinics, spas and cosmetic centers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Botulinum Neurotoxins Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Botulinum Neurotoxins Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Botulinum Neurotoxins Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Botulinum Neurotoxins Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Botulinum Neurotoxins Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Botulinum Neurotoxins Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Botulinum Neurotoxins market in the global market. Below mentioned is the list of few companies engaged in the Botulinum Neurotoxins Market.

The report also includes the profiles of key players in Botulinum Neurotoxins Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Allergan
- Merz Pharma
- Eisai Co., Ltd.
- Galderma S.A
- Hugel Inc.
- Medytox Inc.
- Hugh Source International Ltd.
- Ipsen
- Revance Therapeutics, Inc.
- Lanzhou Institute of Biological Products Co. Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Botulinum Neurotoxins Market - By Product
1.3.2 Botulinum Neurotoxins Market - By Application
1.3.3 Botulinum Neurotoxins Market - By Gender
1.3.4 Botulinum Neurotoxins Market - By End- Use
1.3.5 Botulinum Neurotoxins Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. BOTULINUM NEUROTOXINS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. BOTULINUM NEUROTOXINS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BOTULINUM NEUROTOXINS MARKET - GLOBAL MARKET ANALYSIS
6.1. BOTULINUM NEUROTOXINS - GLOBAL MARKET OVERVIEW
6.2. BOTULINUM NEUROTOXINS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. BOTULINUM NEUROTOXINS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. BOTULINUM TOXIN A
7.3.1. Overview
7.3.2. Botulinum toxin A Market Forecast and Analysis
7.4. BOTULINUM TOXIN B
7.4.1. Overview
7.4.2. Botulinum toxin B Market Forecast and Analysis
8. BOTULINUM NEUROTOXINS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. MEDICAL
8.3.1. Overview
8.3.2. Medical Market Forecast and Analysis
8.4. AESTHETIC
8.4.1. Overview
8.4.2. Aesthetic Market Forecast and Analysis
9. BOTULINUM NEUROTOXINS MARKET - REVENUE AND FORECASTS TO 2027 - GENDER
9.1. OVERVIEW
9.2. GENDER MARKET FORECASTS AND ANALYSIS
9.3. FEMALE
9.3.1. Overview
9.3.2. Female Market Forecast and Analysis
9.4. MALE
9.4.1. Overview
9.4.2. Male Market Forecast and Analysis
10. BOTULINUM NEUROTOXINS MARKET - REVENUE AND FORECASTS TO 2027 - END- USE
10.1. OVERVIEW
10.2. END- USE MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. DERMATOLOGY CLINICS
10.4.1. Overview
10.4.2. Dermatology Clinics Market Forecast and Analysis
10.5. SPAS AND COSMETIC CENTERS
10.5.1. Overview
10.5.2. Spas and cosmetic centers Market Forecast and Analysis

11. BOTULINUM NEUROTOXINS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Botulinum Neurotoxins Market Overview
11.1.2 North America Botulinum Neurotoxins Market Forecasts and Analysis
11.1.3 North America Botulinum Neurotoxins Market Forecasts and Analysis - By Product
11.1.4 North America Botulinum Neurotoxins Market Forecasts and Analysis - By Application
11.1.5 North America Botulinum Neurotoxins Market Forecasts and Analysis - By Gender
11.1.6 North America Botulinum Neurotoxins Market Forecasts and Analysis - By End- Use
11.1.7 North America Botulinum Neurotoxins Market Forecasts and Analysis - By Countries
11.1.7.1 United States Botulinum Neurotoxins Market
11.1.7.1.1 United States Botulinum Neurotoxins Market by Product
11.1.7.1.2 United States Botulinum Neurotoxins Market by Application
11.1.7.1.3 United States Botulinum Neurotoxins Market by Gender
11.1.7.1.4 United States Botulinum Neurotoxins Market by End- Use
11.1.7.2 Canada Botulinum Neurotoxins Market
11.1.7.2.1 Canada Botulinum Neurotoxins Market by Product
11.1.7.2.2 Canada Botulinum Neurotoxins Market by Application
11.1.7.2.3 Canada Botulinum Neurotoxins Market by Gender
11.1.7.2.4 Canada Botulinum Neurotoxins Market by End- Use
11.1.7.3 Mexico Botulinum Neurotoxins Market
11.1.7.3.1 Mexico Botulinum Neurotoxins Market by Product
11.1.7.3.2 Mexico Botulinum Neurotoxins Market by Application
11.1.7.3.3 Mexico Botulinum Neurotoxins Market by Gender
11.1.7.3.4 Mexico Botulinum Neurotoxins Market by End- Use
11.2. EUROPE
11.2.1 Europe Botulinum Neurotoxins Market Overview
11.2.2 Europe Botulinum Neurotoxins Market Forecasts and Analysis
11.2.3 Europe Botulinum Neurotoxins Market Forecasts and Analysis - By Product
11.2.4 Europe Botulinum Neurotoxins Market Forecasts and Analysis - By Application
11.2.5 Europe Botulinum Neurotoxins Market Forecasts and Analysis - By Gender
11.2.6 Europe Botulinum Neurotoxins Market Forecasts and Analysis - By End- Use
11.2.7 Europe Botulinum Neurotoxins Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Botulinum Neurotoxins Market
11.2.7.1.1 Germany Botulinum Neurotoxins Market by Product
11.2.7.1.2 Germany Botulinum Neurotoxins Market by Application
11.2.7.1.3 Germany Botulinum Neurotoxins Market by Gender
11.2.7.1.4 Germany Botulinum Neurotoxins Market by End- Use
11.2.7.2 France Botulinum Neurotoxins Market
11.2.7.2.1 France Botulinum Neurotoxins Market by Product
11.2.7.2.2 France Botulinum Neurotoxins Market by Application
11.2.7.2.3 France Botulinum Neurotoxins Market by Gender
11.2.7.2.4 France Botulinum Neurotoxins Market by End- Use
11.2.7.3 Italy Botulinum Neurotoxins Market
11.2.7.3.1 Italy Botulinum Neurotoxins Market by Product
11.2.7.3.2 Italy Botulinum Neurotoxins Market by Application
11.2.7.3.3 Italy Botulinum Neurotoxins Market by Gender
11.2.7.3.4 Italy Botulinum Neurotoxins Market by End- Use
11.2.7.4 Spain Botulinum Neurotoxins Market
11.2.7.4.1 Spain Botulinum Neurotoxins Market by Product
11.2.7.4.2 Spain Botulinum Neurotoxins Market by Application
11.2.7.4.3 Spain Botulinum Neurotoxins Market by Gender
11.2.7.4.4 Spain Botulinum Neurotoxins Market by End- Use
11.2.7.5 United Kingdom Botulinum Neurotoxins Market
11.2.7.5.1 United Kingdom Botulinum Neurotoxins Market by Product
11.2.7.5.2 United Kingdom Botulinum Neurotoxins Market by Application
11.2.7.5.3 United Kingdom Botulinum Neurotoxins Market by Gender
11.2.7.5.4 United Kingdom Botulinum Neurotoxins Market by End- Use
11.2.7.6 Rest of Europe Botulinum Neurotoxins Market
11.2.7.6.1 Rest of Europe Botulinum Neurotoxins Market by Product
11.2.7.6.2 Rest of Europe Botulinum Neurotoxins Market by Application
11.2.7.6.3 Rest of Europe Botulinum Neurotoxins Market by Gender
11.2.7.6.4 Rest of Europe Botulinum Neurotoxins Market by End- Use
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Botulinum Neurotoxins Market Overview
11.3.2 Asia-Pacific Botulinum Neurotoxins Market Forecasts and Analysis
11.3.3 Asia-Pacific Botulinum Neurotoxins Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Botulinum Neurotoxins Market Forecasts and Analysis - By Application
11.3.5 Asia-Pacific Botulinum Neurotoxins Market Forecasts and Analysis - By Gender
11.3.6 Asia-Pacific Botulinum Neurotoxins Market Forecasts and Analysis - By End- Use
11.3.7 Asia-Pacific Botulinum Neurotoxins Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Botulinum Neurotoxins Market
11.3.7.1.1 Australia Botulinum Neurotoxins Market by Product
11.3.7.1.2 Australia Botulinum Neurotoxins Market by Application
11.3.7.1.3 Australia Botulinum Neurotoxins Market by Gender
11.3.7.1.4 Australia Botulinum Neurotoxins Market by End- Use
11.3.7.2 China Botulinum Neurotoxins Market
11.3.7.2.1 China Botulinum Neurotoxins Market by Product
11.3.7.2.2 China Botulinum Neurotoxins Market by Application
11.3.7.2.3 China Botulinum Neurotoxins Market by Gender
11.3.7.2.4 China Botulinum Neurotoxins Market by End- Use
11.3.7.3 India Botulinum Neurotoxins Market
11.3.7.3.1 India Botulinum Neurotoxins Market by Product
11.3.7.3.2 India Botulinum Neurotoxins Market by Application
11.3.7.3.3 India Botulinum Neurotoxins Market by Gender
11.3.7.3.4 India Botulinum Neurotoxins Market by End- Use
11.3.7.4 Japan Botulinum Neurotoxins Market
11.3.7.4.1 Japan Botulinum Neurotoxins Market by Product
11.3.7.4.2 Japan Botulinum Neurotoxins Market by Application
11.3.7.4.3 Japan Botulinum Neurotoxins Market by Gender
11.3.7.4.4 Japan Botulinum Neurotoxins Market by End- Use
11.3.7.5 South Korea Botulinum Neurotoxins Market
11.3.7.5.1 South Korea Botulinum Neurotoxins Market by Product
11.3.7.5.2 South Korea Botulinum Neurotoxins Market by Application
11.3.7.5.3 South Korea Botulinum Neurotoxins Market by Gender
11.3.7.5.4 South Korea Botulinum Neurotoxins Market by End- Use
11.3.7.6 Rest of Asia-Pacific Botulinum Neurotoxins Market
11.3.7.6.1 Rest of Asia-Pacific Botulinum Neurotoxins Market by Product
11.3.7.6.2 Rest of Asia-Pacific Botulinum Neurotoxins Market by Application
11.3.7.6.3 Rest of Asia-Pacific Botulinum Neurotoxins Market by Gender
11.3.7.6.4 Rest of Asia-Pacific Botulinum Neurotoxins Market by End- Use
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Botulinum Neurotoxins Market Overview
11.4.2 Middle East and Africa Botulinum Neurotoxins Market Forecasts and Analysis
11.4.3 Middle East and Africa Botulinum Neurotoxins Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Botulinum Neurotoxins Market Forecasts and Analysis - By Application
11.4.5 Middle East and Africa Botulinum Neurotoxins Market Forecasts and Analysis - By Gender
11.4.6 Middle East and Africa Botulinum Neurotoxins Market Forecasts and Analysis - By End- Use
11.4.7 Middle East and Africa Botulinum Neurotoxins Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Botulinum Neurotoxins Market
11.4.7.1.1 South Africa Botulinum Neurotoxins Market by Product
11.4.7.1.2 South Africa Botulinum Neurotoxins Market by Application
11.4.7.1.3 South Africa Botulinum Neurotoxins Market by Gender
11.4.7.1.4 South Africa Botulinum Neurotoxins Market by End- Use
11.4.7.2 Saudi Arabia Botulinum Neurotoxins Market
11.4.7.2.1 Saudi Arabia Botulinum Neurotoxins Market by Product
11.4.7.2.2 Saudi Arabia Botulinum Neurotoxins Market by Application
11.4.7.2.3 Saudi Arabia Botulinum Neurotoxins Market by Gender
11.4.7.2.4 Saudi Arabia Botulinum Neurotoxins Market by End- Use
11.4.7.3 U.A.E Botulinum Neurotoxins Market
11.4.7.3.1 U.A.E Botulinum Neurotoxins Market by Product
11.4.7.3.2 U.A.E Botulinum Neurotoxins Market by Application
11.4.7.3.3 U.A.E Botulinum Neurotoxins Market by Gender
11.4.7.3.4 U.A.E Botulinum Neurotoxins Market by End- Use
11.4.7.4 Rest of Middle East and Africa Botulinum Neurotoxins Market
11.4.7.4.1 Rest of Middle East and Africa Botulinum Neurotoxins Market by Product
11.4.7.4.2 Rest of Middle East and Africa Botulinum Neurotoxins Market by Application
11.4.7.4.3 Rest of Middle East and Africa Botulinum Neurotoxins Market by Gender
11.4.7.4.4 Rest of Middle East and Africa Botulinum Neurotoxins Market by End- Use
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Botulinum Neurotoxins Market Overview
11.5.2 South and Central America Botulinum Neurotoxins Market Forecasts and Analysis
11.5.3 South and Central America Botulinum Neurotoxins Market Forecasts and Analysis - By Product
11.5.4 South and Central America Botulinum Neurotoxins Market Forecasts and Analysis - By Application
11.5.5 South and Central America Botulinum Neurotoxins Market Forecasts and Analysis - By Gender
11.5.6 South and Central America Botulinum Neurotoxins Market Forecasts and Analysis - By End- Use
11.5.7 South and Central America Botulinum Neurotoxins Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Botulinum Neurotoxins Market
11.5.7.1.1 Brazil Botulinum Neurotoxins Market by Product
11.5.7.1.2 Brazil Botulinum Neurotoxins Market by Application
11.5.7.1.3 Brazil Botulinum Neurotoxins Market by Gender
11.5.7.1.4 Brazil Botulinum Neurotoxins Market by End- Use
11.5.7.2 Argentina Botulinum Neurotoxins Market
11.5.7.2.1 Argentina Botulinum Neurotoxins Market by Product
11.5.7.2.2 Argentina Botulinum Neurotoxins Market by Application
11.5.7.2.3 Argentina Botulinum Neurotoxins Market by Gender
11.5.7.2.4 Argentina Botulinum Neurotoxins Market by End- Use
11.5.7.3 Rest of South and Central America Botulinum Neurotoxins Market
11.5.7.3.1 Rest of South and Central America Botulinum Neurotoxins Market by Product
11.5.7.3.2 Rest of South and Central America Botulinum Neurotoxins Market by Application
11.5.7.3.3 Rest of South and Central America Botulinum Neurotoxins Market by Gender
11.5.7.3.4 Rest of South and Central America Botulinum Neurotoxins Market by End- Use

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. BOTULINUM NEUROTOXINS MARKET, KEY COMPANY PROFILES
13.1. ALLERGAN
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. MERZ PHARMA
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. EISAI CO., LTD
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GALDERMA S.A
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. HUGEL INC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MEDYTOX INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. HUGH SOURCE INTERNATIONAL LTD
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. IPSEN
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. REVANCE THERAPEUTICS, INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO. LTD
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Allergan
2. Merz Pharma
3. Eisai Co., Ltd
4. Galderma S.A
5. Hugel Inc
6. Medytox Inc
7. Hugh Source International ltd
8. Ipsen
9. Revance Therapeutics, Inc
10. Lanzhou Institute of Biological Products Co. Ltd
TIPRE00018824
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking